Purchase Order 75N95023P00217
Award Date 5/28/23
Potential Completion Date 5/27/27
Potential Value $120K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a license and warranty for a PromethION 48 DNA/RNA sequencing system, with a period of performance through October 27, 2029. Oxford Nanopore Technologies has secured multiple prime contracts and...
- This is a $232,150 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian federal agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of PROMETHION FLOW CELL PACKS, which are a key consumable component of Oxford Nanopore's PromethION sequencing platform. The contract has a period of performance through May 1, 2028. Oxford Nanopore Technologies Inc. is an established federal...
- The National Institute on Aging awarded a $24,995 firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for software licenses and device warranty services related to the PromethION-24 sequencer. The contract was awarded on August 15, 2025, with an ultimate completion date of August 14, 2026, and will be performed in New York, NY. This award carries no set-aside designation and represents Oxford Nanopore's continued provision of next-generation sequencing technologies to federal...
- This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
- This is a $24,950 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a PROMETHION SEQUENCING INSTRUMENT AND REAGENT STARTER PACKAGE, with a performance period ending on May 21, 2026. Oxford Nanopore Technologies Inc. is the prime contractor and there are no subcontractors mentioned. The contract is not...
- This is a $23,050.00 firm fixed price purchase order awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of a PromethION 2 Solo CAPEX Sequencing Unit, a next-generation genomic sequencing platform developed by Oxford Nanopore. This award is not associated with a set-aside program and is the latest in a...
- This federal contract award, valued at $22,600, was issued by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the procurement of SCIENTIFIC EQUIPMENT - PROMETHION FLOW CELLS, with a completion date of Nov 15, 2024. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for analyzing single molecules, including DNA, RNA,...
- This federal contract award is for the provision of Oxford Nanopore long read sequencing kits to the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The $550,333 firm-fixed-price purchase order was awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company specializing in nanopore-based sequencing technologies. The contract does not have a set-aside designation. The contract was awarded to administratively...
- This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
- This is a $12,500 firm-fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS) to Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company, for a software license and warranty for a GridION system. The period of performance is from February 1, 2023, to January 31, 2024. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic sequencing equipment, consumables, reagents, software licenses, and associated services to...